Pediatric Influenza Prevention and Control

Nicola Principi, Susanna Esposito

Research output: Contribution to journalArticlepeer-review

Abstract

Global evaluation of influenza vaccination in children indicates that current recommendations are not followed. Most children at high risk for influenza-related complications do not receive the vaccine, and increased efforts are needed to protect them. Furthermore, vaccinating healthy infants 6-23 months of age and their close contacts should be strongly encouraged. Vaccinations are recommended for children with recurrent acute otitis media or recurrent respiratory tract infections and possibly for healthy daycare and school-age children because of the potential socioeconomic implications of influenza. Issues that need to be addressed include educating physicians and parents concerning influenza-related illness and complications, cost-effectiveness and safety of licensed vaccines, adequate vaccine supply, and availability of intranasal products.

Original languageEnglish
Pages (from-to)574-580
Number of pages7
JournalEmerging Infectious Diseases
Volume10
Issue number4
Publication statusPublished - Apr 2004

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Pediatric Influenza Prevention and Control'. Together they form a unique fingerprint.

Cite this